NECTAR LIFESCIENCES
Smallcap | BSE
Sector
Index
Here's the live share price of Nectar Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.76₹ -0.21
As on Sep 11, 2026, 04:01 PM IST
Source: Dion Global
Nectar Lifesciences Price Performance
Today's LowToday's High
₹11.45₹12.10
₹11.74
52 Weeks' Low52 Weeks' High
₹9.20₹22.49
₹11.74
Open Price
₹12.10
Prev. Close
₹11.95
Volume
23,477
Source: Dion Global
Nectar Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Nectar Lifesciences | -3.93 | 11.28 | 4.26 | 2.80 | -21.79 | -23.63 | -16.63 |
| Sun Pharmaceutical Industries | -3.00 | -5.05 | 2.66 | 0.94 | 14.44 | 17.44 | 18.75 |
| Divi's Laboratories | 2.48 | 9.24 | 40.21 | 46.89 | 55.09 | 35.68 | 12.89 |
| Torrent Pharmaceuticals | 2.58 | 2.20 | 8.86 | 12.32 | 38.96 | 38.62 | 26.07 |
| Zydus Lifesciences | -0.13 | -5.13 | 1.25 | 21.42 | 7.28 | 21.21 | 15.05 |
| Cipla | -1.44 | -6.63 | -1.30 | 2.64 | -12.55 | 3.07 | 7.51 |
| Laurus Labs | 7.08 | 5.93 | 41.70 | 89.43 | 120.18 | 69.19 | 24.99 |
| Aurobindo Pharma | 1.34 | 2.04 | 14.44 | 28.43 | 50.99 | 24.52 | 17.88 |
| Dr. Reddy's Laboratories | 0.61 | -3.65 | -8.94 | -12.41 | -10.93 | 1.13 | 3.31 |
| Lupin | -0.71 | -7.99 | -7.83 | -10.64 | 5.40 | 22.94 | 16.33 |
| Mankind Pharma | -2.21 | -6.10 | -3.99 | 1.50 | -12.31 | 8.80 | 9.84 |
| Glenmark Pharmaceuticals | -0.42 | 5.54 | 12.71 | 6.35 | 13.63 | 43.92 | 36.03 |
| Biocon | -1.59 | -9.08 | -6.20 | -1.11 | 7.45 | 12.25 | 2.03 |
| Alkem Laboratories | -1.97 | -7.63 | -4.00 | -8.04 | -5.70 | 11.91 | 5.85 |
| Abbott India | -1.93 | -8.71 | -1.93 | -6.03 | -17.45 | 3.61 | 3.60 |
| Anthem Biosciences | 0.44 | 5.18 | 20.27 | 44.65 | 14.34 | 8.70 | 5.13 |
| Ipca Laboratories | 0.10 | 12.45 | 21.95 | 28.38 | 49.90 | 29.83 | 8.68 |
| Gland Pharma | -0.08 | 0.20 | 27.09 | 75.91 | 49.07 | 20.30 | -5.12 |
| GlaxoSmithKline Pharmaceuticals | -4.34 | 8.98 | 34.59 | 13.88 | -1.18 | 24.68 | 12.96 |
| Ajanta Pharma | 2.10 | 0.96 | 12.64 | 16.15 | 37.46 | 26.89 | 19.98 |
Source: Dion Global
Over the last one year, Nectar Lifesciences has declined 21.79% compared to peers like Sun Pharmaceutical Industries (14.44%), Divi's Laboratories (55.09%), Torrent Pharmaceuticals (38.96%). From a 5 year perspective, Nectar Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (18.75%) and Divi's Laboratories (12.89%).
Nectar Lifesciences Financials
Source: Dion Global
Nectar Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 12.16 | 12.14 |
| 10 | 12.32 | 12.07 |
| 20 | 11.69 | 11.78 |
| 50 | 11.16 | 11.49 |
| 100 | 11.67 | 11.78 |
| 200 | 13.28 | 13.33 |
Source: Dion Global
Nectar Lifesciences Share Holding Pattern
In the latest quarter, Nectar Lifesciences remained same as its previous close in promoter holding, while DII stake decreased to 3.74%, FII holding fell to 0.50%, and public shareholding moved up to 43.90% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Nectar Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 22, 2026, 08:03 PM IST IST | Nectar Lifesciences - Letter Sent To Members |
| Aug 20, 2026, 05:12 PM IST IST | Nectar Lifesciences - Reg. 34 (1) Annual Report. |
| Aug 20, 2026, 04:30 PM IST IST | Nectar Lifesciences - Notice Of 31St Annual General Meeting ('AGM') For The Financial Year 2025-26 |
| Aug 15, 2026, 05:10 PM IST IST | Nectar Lifesciences - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address |
| Aug 15, 2026, 02:44 AM IST IST | Nectar Lifesciences - Book Closure/ Cut-Off Date For The Purpose Of 31St Annual General Meeting (''AGM'') For The Financial |
Source: Dion Global
About Nectar Lifesciences
Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 19.43 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressVillage Saidpura, Tehsil Derabassi, Mohali Punjab 140507
- Contact
Source: Dion Global
Management
- Mr. Sanjiv GoyalChairman & Managing Director
- Dr. Gunmala SuriNon Exe.Non Ind.Director
- Ms. Sushil KapoorDirector - Finance
- Dr. Indu Pal KaurIndependent Director
- Dr. Rupinder TewariIndependent Director
- Dr. Kuldip Kumar BhasinIndependent Director
FAQs on Nectar Lifesciences Share Price
What is the share price of Nectar Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Nectar Lifesciences is ₹11.74 as on Sep 11, 2026.
What kind of stock is Nectar Lifesciences?
The Nectar Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Nectar Lifesciences?
The market cap of Nectar Lifesciences is ₹263.28 Cr as on Sep 11, 2026.
What are today's High and Low prices of Nectar Lifesciences?
Today’s highest and lowest price of Nectar Lifesciences are ₹12.10 and ₹11.45.
What are the 52 Week High and 52 Week Low of Nectar Lifesciences?
The 52-week high/low is the highest and lowest price at which Nectar Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Nectar Lifesciences is ₹22.49 and 52-week low of Nectar Lifesciences is ₹9.20 as on Sep 11, 2026.
How has the Nectar Lifesciences performed historically in terms of returns?
The Nectar Lifesciences has shown returns of -1.76% over the past day, 11.28% for the past month, 4.26% over 3 months, -21.79% over 1 year, -23.63% across 3 years, and -16.63% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Nectar Lifesciences?
P/E ratio of and PB ratio of Nectar Lifesciences are -1.07 and 0.46 on Sep 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕